Most of these cyclin D1 partners in B-cell lymphoma and myeloma cells, are also present in solid tumours (breast cancer, squamous cell carcinoma and colorectal cancer)4, further validating our technical protocol. This evidence concerns the gene CCND1 and B-cell non-Hodgkin lymphoma.